|Credit CDC Infographic|
Three months ago the alarm was raised (see PICS: NHS Alert On Possible Severe Pediatric COVID-19 Complication) in the UK regarding children with a severe inflammatory syndrome similar to Kawasaki Disease, which seemed to be linked COVID-19 infection.
Since then, this syndrome has been identified in children around the world - and while the numbers remain small - surveillance and reporting are still in their infancy.
The CDC describes the syndrome on their MIS-C website as:
What is MIS-C?Multisystem inflammatory syndrome in children (MIS-C) is a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs. Children with MIS-C may have a fever and various symptoms, including abdominal (gut) pain, vomiting, diarrhea, neck pain, rash, bloodshot eyes, or feeling extra tired. We do not yet know what causes MIS-C. However, many children with MIS-C had the virus that causes COVID-19, or had been around someone with COVID-19.
The CDC has an infographic on MIS-C, but the data is only current through May 20th. The CDC has posted a notice they will update these numbers soon, but for now the data is nearly 2 months old. The number of cases today is almost certainly much higher.
This afternoon the CDC will hold their second COCA Call on MIS-C, to provide clinicians with the latest clinical guidance for the syndrome. An archived video is generally posted within 24 hours, to allow those who were not able to attend the live stream access.
Clinical Management of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)
During this COCA Call, clinicians will learn about clinical management of multisystem inflammatory syndrome in children (MIS-C) associated with Coronavirus Disease 2019 (COVID-19). Clinicians will share their experiences treating patients with MIS-C, present treatment details from published literature on patients with MIS-C, and provide an overview of the treatment guidelines published by the American College of Rheumatology.
Ermias Belay, MD
MIS-C Team Lead
Centers for Disease Control and Prevention
Eva Cheung, MD
Assistant Professor of Pediatrics – Divisions of Pediatric Cardiology and Critical Care Medicine
Columbia University Irving Medical Center/NewYork-Presbyterian Morgan Stanley Children’s Hospital
Matthew Oster, MD, MPH
CDC COVID-19 Response, MIS-C Team
Associate Professor of Pediatrics
Children’s Healthcare of Atlanta, Sibley Heart Center
Emory University School of Medicine
Adriana Tremoulet, MD
Professor of Pediatrics and Associate Director of the Kawasaki Disease Research Center
University of California, San Diego and Rady Children’s Hospital San Diego
When: Thursday, July 16, 2020,
2:00 p.m. to 3:00 p.m. (Eastern Time)
US: +1 669 254 5252 or +1 646 828 7666
International numbersexternal icon
US: +16692545252,,1612204810# or +16468287666,,1612204810#
Webinar ID: 161 220 4810Add to Calendar